Quest Diagnostics Inc (DGX) Dividend Safety
- Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2026-06-30..
Dividend safety
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | (m) | Cash dividends paid / net income. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | (m) | |
| Net income · 12 months | 1.06B USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-06-30 | (m) | $1.06B | (m) |
| 2026-03-31 | (m) | $1.02B | (m) |
| 2025-12-31 | (m) | $992.00M | (m) |
| 2025-09-30 | (m) | $969.00M | (m) |
| 2025-06-30 | (m) | $950.00M | (m) |
| 2025-03-31 | (m) | $897.00M | (m) |
| 2024-12-31 | (m) | $871.00M | (m) |
| 2024-09-30 | (m) | $841.00M | (m) |
| 2024-06-30 | (m) | $840.00M | (m) |
| 2024-03-31 | (m) | $846.00M | (m) |
| 2023-12-31 | (m) | $854.00M | (m) |
| 2023-09-30 | (m) | $763.00M | (m) |
| 2023-06-30 | (m) | $794.00M | (m) |
| 2023-03-31 | (m) | $793.00M | (m) |
| 2022-12-31 | (m) | $946.00M | (m) |
| 2022-09-30 | (m) | $1.24B | (m) |
| 2022-06-30 | (m) | $1.48B | (m) |
| 2022-03-31 | (m) | $1.88B | (m) |
| 2021-12-31 | (m) | $2.00B | (m) |
| 2021-09-30 | (m) | $2.18B | (m) |
| 2021-06-30 | (m) | $2.25B | (m) |
| 2021-03-31 | (m) | $1.80B | (m) |
| 2020-12-31 | (m) | $1.43B | (m) |
| 2020-09-30 | (m) | $1.10B | (m) |
| 2020-06-30 | (m) | $752.00M | (m) |
| 2020-03-31 | (m) | $793.00M | (m) |
| 2019-12-31 | (m) | $858.00M | (m) |
| 2019-09-30 | (m) | $732.00M | (m) |
| 2019-06-30 | (m) | $730.00M | (m) |
| 2019-03-31 | (m) | $723.00M | (m) |
| 2018-12-31 | (m) | $736.00M | (m) |
| 2018-09-30 | (m) | $863.00M | (m) |
| 2018-06-30 | (m) | $811.00M | (m) |
| 2018-03-31 | (m) | $785.00M | (m) |
| 2017-12-31 | (m) | $772.00M | (m) |
| 2017-09-30 | (m) | $673.00M | (m) |
| 2017-06-30 | (m) | $704.00M | (m) |
| 2017-03-31 | (m) | $706.00M | (m) |
| 2016-12-31 | (m) | $645.00M | (m) |
| 2016-09-30 | (m) | $678.00M | (m) |
| 2016-06-30 | (m) | $828.00M | (m) |
| 2016-03-31 | (m) | $750.00M | (m) |
| 2015-12-31 | (m) | $709.00M | (m) |
| 2015-09-30 | (m) | $711.00M | (m) |
| 2015-06-30 | (m) | $498.00M | (m) |
| 2015-03-31 | (m) | $513.00M | (m) |
| 2014-12-31 | (m) | $556.00M | (m) |
| 2014-09-30 | (m) | $509.00M | (m) |
| 2014-06-30 | (m) | $785.00M | (m) |
| 2014-03-31 | (m) | $817.00M | (m) |
| 2013-12-31 | (m) | $849.00M | (m) |
| 2013-09-30 | (m) | $762.21M | (m) |
| 2013-06-30 | (m) | $520.14M | (m) |
| 2013-03-31 | (m) | $532.38M | (m) |
| 2012-12-31 | (m) | $555.72M | (m) |
| 2012-09-30 | (m) | $689.34M | (m) |
| 2012-06-30 | (m) | $698.11M | (m) |
| 2012-03-31 | (m) | $683.55M | (m) |
| 2011-12-31 | (m) | $470.57M | (m) |
| 2011-09-30 | (m) | $446.89M | (m) |
| 2011-06-30 | (m) | $473.11M | (m) |
| 2011-03-31 | (m) | $504.58M | (m) |
| 2010-12-31 | (m) | $720.89M | (m) |
| 2010-09-30 | (m) | $736.73M | (m) |
| 2010-06-30 | (m) | $730.87M | (m) |
| 2010-03-31 | (m) | $724.46M | (m) |
| 2009-12-31 | (m) | $729.11M | (m) |
| 2009-09-30 | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) |
| 2009-03-31 | (m) | (m) | (m) |
| 2008-12-31 | (m) | $581.49M | (m) |
| 2008-09-30 | (m) | (m) | (m) |
| 2008-06-30 | (m) | (m) | (m) |
| 2007-12-31 | (m) | $339.94M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |